КОРДІПРАЗ

Product Overview

About КОРДІПРАЗ

КОРДІПРАЗ is a prescription medication containing the active ingredient Prasugrel, a thienopyridine antiplatelet agent used to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or myocardial infarction (MI). It works by inhibiting platelet activation and aggregation, thereby preventing the formation of blood clots.

Key Benefits & Uses

• Reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or myocardial infarction (MI)
• Prevents the formation of blood clots in patients undergoing percutaneous coronary intervention (PCI)
• May be used in combination with aspirin to reduce the risk of thrombotic events in patients with a history of ischemic stroke or transient ischemic attack (TIA)

Active Ingredient & Action

Prasugrel, the active ingredient in КОРДІПРАЗ, is a prodrug that is metabolized to its active form, R-138727. This active form selectively and irreversibly binds to the P2Y12 receptor on platelet membranes, thereby inhibiting platelet activation and aggregation. As a result, the formation of blood clots is reduced, and the risk of thrombotic cardiovascular events is decreased.

Important Notes

КОРДІПРАЗ should only be used under the guidance of a healthcare professional. It is essential to inform your doctor about any medical conditions, allergies, or medications you are currently taking before starting treatment. Common side effects of КОРДІПРАЗ may include bleeding, bruising, or thrombocytopenia. In rare cases, more severe side effects may occur, such as anaphylaxis or Stevens-Johnson syndrome. If you experience any unusual symptoms or side effects, seek medical attention immediately.